FDA-approved as Wegovy (chronic weight management) and Ozempic (T2D)
At 176 weeks, the study participants with both obesity and prediabetes on the 15-mg (highest) dose lost an average of 19.7% of their weight
Moreover, a serious limitation with these datasets is the lack of sufficient patient level data to assess key variables, including other PDAC risk factors (particularly diabetes and obesity) as well as dosing and duration of drug exposure
J., Charpentier, G., Ostgren, C
Cagrilintide (CAGRI) 5mg Lyophilized Research Peptide Cagrilintide (research code AM833), listed in research catalogs as CAGRI , is a long-acting amylin analog studied in metabolic research models for its role in appetite regulation, satiety signaling, and energy balance
LEADER (9,340 participants, median 3.8 years) showed liraglutide reduced major adverse cardiovascular events compared with placebo (HR 0.87